Blood Coagulation & Fibrinolysis

Article	Citations
Multiple thrombotic sources and embolic events at arterial sites in a patient with protein-C deficiency	64
Anticoagulation management post-transjugular intrahepatic portosystemic shunt in portal hypertension associated with myeloproliferative neoplasms	18
Coexpression of factor VIII and factor von Willebrand variants in a woman with heavy menstrual bleeding	17
New treatments for primary immune thrombocytopenia	17
Lupus anticoagulant activity and thrombosis post COVID-19 vaccination	13
Interleukin-10 levels and the risk of thromboembolism according to COMPASS-Cancer associated thrombosis score in breast cancer patients prior to undergoing doxorubicin-based chemotherapy	13
New approaches to the genetic study of bleeding diathesis in our center: from sanger to next-generation sequencing	11
Genotypes and phenotypes characterization of 17 Iranian patients with inherited factor X deficiency: identification of a novel mutation: Leu487Phe	11
Comparing fondaparinux and low molecular weight heparin for thromboprophylaxis after hip and knee arthroplasty: a systematic review and meta-analysis	10
An atypical presentation of catastrophic antiphospholipid syndrome with refractoriness to treatment	9
Clot waveform analysis in hemophilia carriers	9
Bleeding risk in hemophilia A and B carriers: comparison of factor levels determined using chronometric and chromogenic assays	9
A founder effect in hemophilia A patients from Russian Ural region with a new p.(His634Arg) variant in F8 gene	9
Poisoning by butylated hydroxytoluene quinone methide acting as a superwarfarin: first reported case in humans	9
A multicenter, observational study to evaluate hemostasis following recombinant activated FVII treatment in patients in Japan with congenital factor VII deficiency	8
A study of fibrinolytic system components in donor groups depending on various titers of circulating anti-SARS-CoV-2 IgG in the bloodstream	8
Pulmonary vein stump thrombosis after lung resection for lung cancer: clinical features and outcome	7
Characterization of thrombophilia-related plasmas evaluated by anticoagulants-mediated thrombin and plasmin generation assays	7
The determination of euglobulin clot lysis time reference intervals in Beckton Dickinson and Kima 3.2% sodium citrate coagulation tubes	7
Time-in-therapeutic range falls as the target international normalized ratio range increases in patients on warfarin	7
The physiology of hemostasis	7
Obesity and physical exercise in hemophilia	7
Predictive value of miR-24-3p and miR-1277-5p in hemodialysis patients with vascular access thrombosis	7
Direct oral anticoagulant adsorption and laboratory detection of lupus anticoagulant	7
Disability and the social impact of hemophilia	6

The procoagulant potential before and after surgery for endometriosis and its association with disease severity	6
Factor VII Padua in Iran: clinical and laboratory findings of three unrelated patients	6
Glanzmann's thrombasthenia associated with gastrointestinal angiodysplasias successfully treated with bevacizumab	6
Clinical characteristics and outcomes of patients with isolated pulmonary embolism	6
Efficacy of adjusted weight-based dosing of desmopressin (1-deamino-8-d-arginine vasopressin in type 1 von Willebrand disease	6
Risk of venous thromboembolism and endocrine therapy in older women with breast cancer in the United States	6
Safety of Sinopharm vaccine in patients with congenital bleeding disorders under on-demand therapy: a preliminary report	5
Venous thromboembolism secondary prophylaxis in elderly people (over 75 years old) with low-dose direct oral anticoagulants	5
Reduced ADAMTS13 activity and high D-dimer levels are associated with thrombosis in patients with systemic lupus erythematosus	5
Viscoelastic testing to assess the effects of rapid fibrinogen concentrate administration after cardiopulmonary bypass: insights from the REPLACE study	5
Decrease in in vivo coagulant potential of emicizumab in a patient with hemophilia A and inhibitor complicated with infectious mononucleosis	5
Utilization and safety of off-label prothrombin complex concentrate (four-factor prothrombin complex concentrate) in a surgical population	5
Rituximab as a treatment for refractory immune thrombocytopenia during pregnancy	5
CHA2DS2-VASc score in patients with COVID-19 pneumonia and its relationship with biomarkers of thrombosis, inflammation and myocardial injury	5
Rare coagulation factor deficiencies: a five-year experience from a single tertiary care center in South India	5
Acquired Bernard–Soulier syndrome and hypodysfibrinogenaemia because of multiple myeloma	5
Anticoagulant and antiplatelet activity of aqueous extracts of Citrus sinensis and Lippia alba: interactions and potential for the development of antithrombotics	4
A novel F13A1 gene mutation (Arg208Pro) in a Chinese patient with factor XIII deficiency	4
Evaluation of the activated partial thromboplastin time and its influential factors in ischemic heart disease patients under heparin treatment	4
Harmonizing factor assay-related testing performed in a large laboratory network	4
Performance evaluation of the Sysmex CN-6000-automated coagulation analyzers for routine coagulation tests	4
Role of tissue factor pathway inhibitor in hormone-induced venous thromboembolism	4
Fibrinogen reflects severity and predicts outcomes in patients with sepsis and septic shock	4
Comparing the efficacy and safety of direct oral anticoagulants versus Vitamin K antagonists in patients with antiphospholipid syndrome: a systematic review and meta-analysis	4
Congenital factor V deficiency in Taiwan: identification of a novel variant p.Tyr1813∗ and two variants specific to East Asians	4
Is the combination of two automated rapid assays for diagnosis of heparin-induced thrombocytopenia necessary?	4
Why do patients with antiphospholipid syndrome bleed? A clinical paradox	4
Genetic analysis of a pedigree with hereditary coagulation factor XII deficiency	4
Optimizing factor VIII dosing in obese individuals with haemophilia A	4
Tissue factor-dependent coagulation activation in intracranial neoplasms: a comparative study	4
Left ventricular assist device thrombosis in the setting of supratherapeutic international normalized ratio (INR) and bleeding	3
Interpreting coagulation mixing study results in the era of direct oral anticoagulants	3
Patients with severe coronavirus disease 2019 have high frequency of factor 5 Leiden and prothrombin gene mutations	3
Avatrombopag increased platelet count in a patient with chronic immune thrombocytopenia refractory to multiple lines of treatment	3
Severe bleeding diathesis as onset of light-chain amyloidosis: combined excessive fibrinolysis and acquired von Willebrand disease in a young patient	3
Molecular mechanism analysis of a family with hereditary coagulation FXI deficiency caused by compound heterozygous mutations	3
Effects of Momordica charantia exosomes on platelet activation, adhesion, and aggregation	3
Adrenal insufficiency revealing bilateral adrenal hemorrhage related to JAK2 V617F-positive essential thrombocythemia: about two cases	3
Evaluation of a 4 min 4000g centrifugation protocol for routine coagulation assays	3
A rare case of essential thrombocythemia with pseudo-hyperkalemia	3
Lupus anticoagulant hypoprothrombinemia syndrome with multiple and high-titer antiphospholipid antibodies strongly interfered with coagulation assays	3
Direct oral anticoagulant neutralization by activated charcoal DOAC-Remove for thrombophilia screening	3
Disseminated intravascular coagulation in a cohort of adult acute leukemia patients: a single center experience	3
CRISPR/Cas9 mediated generation of zebrafish f9a mutant as a model for hemophilia B	3
Two patients with protein S deficiency and cerebral venous sinus thrombosis: nonsense mutations of the PROS1 gene may account for these deficiencies	3
Analysis of heparin-induced thrombocytopenia diagnostic and management strategies in individuals with inconclusive antibody optical densities	3
The use of andexanet alfa vs. 4-factor prothrombin complex concentrates in the setting of life-threatening intracranial hemorrhage	3
Hemostatic parameters predict 90-day mortality in hospitalized cirrhotic patients with acute decompensation: a prospective cohort study	2
Optimal dosing of bemiparin for deep vein thrombosis treatment in children: a retrospective study	2
Venous thromboembolism in pediatric inflammatory bowel disease: an 11-year population-based nested case–control study in Canada	2

Thrombin generation assay: the present and the future	2
Risk factors for antibody formation in children with hemophilia: methodological aspects and clinical characteristics of the HEMFIL cohort study	2
Disseminated intravascular coagulation in acute leukemia patients	2
Quantifying time from last dose: do direct oral anticoagulant assays correlate with patient's reported last dose	2
Bleeding disorders in Saudi Arabia, causes and prevalence: a review	2
Absence of exaggerated pharmacology by recombinant ADAMTS13 in the rat and monkey	2
Epidemiological study about the mental state of patients after a pulmonary embolism or deep venous thrombosis event	2
Hemorrhagic complications in individuals with liver disease submitted to minor oral surgery	2
Management of autoimmune factor XIII deficiency in a frail, elderly patient	2
Hemostatic cover in orthopedic surgery	2
Effect of hyperbilirubinemia and phototherapy on apoptotic microparticle levels in neonates	2
A 10-year Australian experience of rare intraabdominal venous thrombosis with comparison to deep vein thrombosis and pulmonary embolism	2
Naive haemophilia mice displayed different pattern of cytokine profiles of cytokine profiles changes might be associated with subclinical bleeding	2
Presentation of concurrent thrombotic thrombocytopenic purpura and Graves’ disease	2
Phenotypic variation in severe hemophilia A is related to endogenous thrombin potential and plasma levels of factor VII	2
Mannose-binding lectin-associated serine protease-1 cleaves plasminogen and plasma fibronectin: prefers plasminogen over known fibrinogen substrate	2
Relationship between oxidant-antioxidant status and hypercoagulobility indices in children with iron deficiency anaemia	2
In-vitro thromboelastographic characterization of reconstituted whole blood utilizing cryopreserved platelets	2
Sustained good response to rituximab in acquired von Willebrand syndrome	2
Acquired bleeding disorders secondary to immune checkpoint inhibitors: a case report and systematic literature review	2
Maternal thrombin generation and D-dimer levels in obesity and pregnancy: results from the maternal thrombin generation in obesity and pregnancy (MaTOPs) study	2
A challenging case of heparin-induced skin necrosis without thrombocytopenia	2
Evaluation of coagulation parameters and impact of transfusion on coagulation in patients with beta thalassemia major	2
Characterization of zebrafish coagulation cofactors Fviii and Fv mutants and modeling hemophilia A and factor V deficiency	2
Psychological complications among patients with congenital bleeding disorders	2
Assessment of clinical characteristics and treatment outcomes of pediatric patients with intracardiac thrombosis: a single-center experience	2
Warfarin versus direct oral anticoagulants in South Asian octogenarians: a retrospective review	2
Efficacy of emicizumab therapy in two adult patients with type 3 von Willebrand disease	2
Effect of remote ischemic preconditioning on fibrin formation and metabolism in patients undergoing hip fracture surgery: a randomized clinical trial	2
Epidemiology, diagnosis and management of neonatal thrombosis: a single-center cohort study	2
Clinical and economic implications of false-positive heparin-induced thrombocytopenia immunoassays: utility of the 4T score	2
Measuring coagulopathy in pediatric craniofacial surgery	2
Dysfibrinogenemia: discrepant results following infusion of purified fibrinogen	1
Combination of aspirin and rosuvastatin for reduction of venous thromboembolism in severely injured patients: a double-blind, placebo-controlled, pragmatic randomized phase II clinical trial (The STAT	1
Hematological treatment and prophylaxis in patients with and without inhibitors	1
Self-limited thrombotic thrombocytopenic purpura	1
Incidence of factor XII deficiency in critically ill patients with a prolonged activated partial thromboplastin time: a prospective observational study	1
Biodistribution of recombinant factor IX, extended half-life recombinant factor IX Fc fusion protein, and glycoPEGylated recombinant factor IX in hemophilia B mice	1
The most common disease-causing mutation of factor XIII deficiency is corrected by CRISPR/CAS9 gene editing system	1
Evaluation of ISTH-BAT as a predictor for factor deficiency in haemophilia carriers: a single-centre experience	1
New developments in the diagnosis of primary immune thrombocytopenia	1
Compound heterozygous mutations (p.L68R∗37 and p.T241N) lead to abnormal protein levels and structures in hereditary FVII deficiency	1
Association of hemostasis and inflammation biomarkers with outcomes in acute coronary syndromes	1
New score for predicting thromboembolic events in patients with atrial fibrillation using direct oral anticoagulants	1
Assessment of coagulation assays on Roche Cobas t711 analyzer: performance and clinical implications	1
Acquired factor XIII deficiency and its unprecedented association with multiple myeloma: case report and literature review	1
The impact of neutrophil extracellular traps in coronavirus disease - 2019 pathophysiology	1
Prenatal diagnosis for hemophilia A (intron 22 inversion) reveals a rare association with Klinefelter syndrome with diagnostic difficulties in molecular interpretation	1
Recessively inherited protein C deficiency in two sisters: intracerebral hemorrhage and coagulopathy complications	1
Comparison of bleeding and ischemic events with apixaban vs. rivaroxaban in triple antithrombotic therapy regimens	1
Severe thrombocytopenia associated to bevacizumab in a patient with scleroderma, gastrointestinal angiodysplasias and refractory gastrointestinal bleeding	1
The predictive role of platelet count for bleeding in patients with hepatitis B virus and hepatitis C virus infection	1
Protein S Erlangen: a novel PROS1 gene mutation associated with quantitative protein S deficiency	1
The impact of vascular endothelial glycocalyx on the pathogenesis and treatment of disseminated intravascular coagulation	1
Prolonged prothrombin time does not correlate with clinical bleeding symptoms in newly diagnosed paediatric leukaemia patients	1
The role of genetics in the diagnosis and treatment of haemorrhagic diathesis: a historical perspective	1
True vs. false immune-mediated thrombotic thrombocytopenic purpura exacerbations: a clinical case in the caplacizumab era	1
Coagulopathy following Crotaliπae snakebites in northeast Florida	1
Never too soon to be thinking about heparin-induced thrombocytopenia! A case report of early onset heparin-induced thrombocytopenia	1
Evaluation of D-dimer levels measured by different analytical methods in COVID-19 patients	1
Rotational thromboelastometry for diagnosis of fibrinolysis induced by urokinase in an in-vitro model	1
The impact of intrauterine growth on coagulation and factor XII function in preterm infants	1
Management of surgery, menorrhagia and child-birth for patients with unclassified bleeding disorders: a systematic review of cohort studies	1
Significant difference between coagulation parameters and clinicopathological characteristics in breast cancer	1
Acquired factor V and factor X Deficiency coexisting with acquired dysfibrinogenaemia in a patient with light chain myeloma	1
Challenges in managing severe homozygous protein c deficiency: a case report	1
Nonpharmacological treatment for coping with pain	1
Impact of cytochrome P-450 3A4 enzyme/P-glycoprotein inducing antiseizure medications on direct oral anticoagulant therapy	1
Pharmacokinetics, efficacy and safety of a novel fibrinogen concentrate in pediatric patients with congenital afibrinogenemia	1
Expression and methylation status of vascular endothelial growth factor and thrombospondin-1 genes in congenital factor XIII-deficient patients with intracranial hemorrhage	1
Endothelium-biomarkers for postthrombotic syndrome: a case–control study	1
The role of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as venous thromboembolism predictors in breast cancer patients pre- and post-therapy	1
Is dynamic change in mean platelet volume related with composite endpoint development after transcatheter aortic valve replacement?	1
New under the sun: ClotPro's ECA-test detects hyperfibrinolysis in a higher number of patients, more frequently and 9 min earlier	1
Noninvasive prenatal diagnosis of congenital factor XIII deficiency in Iran	1
Clot waveform analysis in acute promyelocytic leukemia	1
The coexistence of antiβ2 glycoprotein 1 antibody antibody has no effect on hemophilia A patient	1
Efficacy of extended microthrombolysis in an elderly lady with purpura fulminans	1
The impact of von Willebrand factor on fibrin formation and structure unveiled with type 3 von Willebrand disease plasma	1
Identification of a recurrent missense mutation in the FGA gene likely causing a congenital fibrinogen disorder	1

4-Factor prothrombin complex concentrates and factor VIII inhibitor bypass activity use in cardiac surgery	1
Genetic analysis of compound heterozygous pathogenic variants of the F11 gene in two Chinese patients with hereditary factor XI deficiency	1
Homozygous MTHFR C677T carriers develop idiopathic portal vein thrombosis 20 years earlier than wild type	1
Clinical study reveals the efficacy of sirolimus in treating primary immune thrombocytopenia: findings from a single-center study	1
The evaluation of reactive oxygen species generation and free mitochondrial DNA in platelet concentrates during 5 days of storage	1
The role of factor XIII in patient blood management	1
Thrombogenicity markers for early diagnosis and prognosis in COVID-19: a change from the current paradigm?	1
Comment on: coagulopathy following Crotaline snakebites in northeast Florida	1